Back to Rankings

AURA

Aura BiosciencesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
AURA vs peer average
70/100
AURA vs. peer average (A vs. B)
Grade spread
A 2 · B 3 · C 2 · D 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

PALI is the first available peer comparator.

Palisade Bio is a looser micro-cap biotech comp that mainly helps frame downside from weak clinical signal or funding pressure rather than indication-specific benchmarking.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerPALIPalisade Bio
AURA
Aura Biosciences
PALI
Palisade Bio
Grade
A
B
Momentum
79
85
Value
41
41
Sentiment
67
55
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs PALI

AURA / PALI
Grade Position
Above peers
AURA vs. peer average (A vs. B)
70/100
Momentum
79
PALI
Value
41
AURA
Sentiment
67
AURA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AURA
1
PALI
PALI
B
80/100
+1
2
RLMD
RLMD
A
100/100
Even
3
XFOR
XFOR
C
60/100
+2
4
EVMN
Evommune Inc Common
N/A
-
-
5
EIKN
Eikon Therapeutics Inc Common
N/A
-
-
PALI is the first peer returned for this comparison set.